Kallikrein Inhibitor

$90.00$293.00

The synthetic kallikrein inhibitor can attenuates breast cancer cell invasion into the airspace by 33% when quantified by lavage recovery and up to 34% as quantified in the lung interstitium by cytokeratin 18 immunostaining. It indicated tissue kallikrein may participate in the invasion and metastasis of human adenocarcinomas. The newly developed explanted rodent lung assay can be useful for the study of cancer cells, neutrophils, or other extravasating cells.

Clear
Catalog No.: N/A Category:

Sequence (One-Letter Code):

AC-PFRSVQ-NH2

 

Sequence (Three-Letter Code):

Ac-{Pro}{Phe}{Arg}{Ser}{Val}{Gln}-NH2

 

Molecular Weight:

773.9

 

Purity:
% Peak Area By HPLC ≥ 95%

 

Salt:
TFA Salt

 

Storage:

Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.

 

Note:

This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.

 

Documents:

MSDS

Amount

1 mg, 5 mg, Other